-
1
New Diarylamine K<sub>V</sub>10.1 Inhibitors and Their Anticancer Potential
Published 2022-09-01Subjects: Get full text
Article -
2
3D Pharmacophore-Based Discovery of Novel K<sub>V</sub>10.1 Inhibitors with Antiproliferative Activity
Published 2021-03-01Subjects: Get full text
Article -
3
Identification, Synthesis, Conformation and Activity of an Insulin-like Peptide from a Sea Anemone
Published 2021-11-01“…IlO1_i1 did not bind to the insulin or insulin-like growth factor receptors, but showed weak activity against K<sub>V</sub>1.2, 1.3, 3.1, and 11.1 (hERG) channels, as well as Na<sub>V</sub>1.4 channels. …”
Get full text
Article -
4
Biochemical and Electrophysiological Characterization of Two Sea Anemone Type 1 Potassium Toxins from a Geographically Distant Population of Bunodosoma caissarum
Published 2013-03-01“…Their functional characterization was performed by means of a wide electrophysiological screening on 12 different subtypes of KV channels (KV1.1–KV1.6; KV2.1; KV3.1; KV4.2; KV4.3; hERG and Shaker IR). BcsTx1 shows a high affinity for rKv1.2 over rKv1.6, hKv1.3, Shaker IR and rKv1.1, while Bcstx2 potently blocked rKv1.6 over hKv1.3, rKv1.1, Shaker IR and rKv1.2. …”
Get full text
Article -
5
Structure-Function Studies of Sponge-Derived Compounds on the Cardiac Ca<sub>V</sub>3.1 Channel
Published 2023-02-01“…A selectivity screening showed that these analogs are also active on hERG channels. Collectively, a new class of Ca<sub>V</sub>3 channel inhibitors has been discovered and the structure–function studies provide new insights into the synthetic design of drugs and the mechanism of interaction with T-type Ca<sub>V</sub> channels.…”
Get full text
Article